Literature DB >> 24716997

Induction of therapeutic hypothermia requires modulation of thermoregulatory defenses.

Oliver Bandschapp1, Paul A Iaizzo.   

Abstract

Hypothermia has been linked to beneficial neurologic outcomes in different clinical situations and its therapeutic value is considered important. For example, in asphyctic neonates and in patients with out-of-hospital cardiac arrest (with ventricular fibrillation as the initial cardiac rhythm), rapid installation of hypothermia has been reported to add substantial therapeutic benefits over nonthermal standard treatments. Yet, in other groups of patients in which the application of therapeutic hypothermia may be applied with clinical benefits, the optimization of therapy remains less straightforward, as the body possesses vigorous defense mechanisms to protect it from inducing hypothermia, that is, especially in conscious patients and/or in those in which the hypothalamus remains intact, such as stroke patients or patients who suffer a myocardial infarction or spinal cord injury. This overview summarizes the body's primary reactions to hypothermia and the defense mechanisms available or evoked. Then, clinically applicable ways to overcome these forceful cold defenses of the body are described to ensure both an optimal induction process for therapeutic hypothermia and maximal subjective comfort for these conscious patients.

Entities:  

Year:  2011        PMID: 24716997     DOI: 10.1089/ther.2010.0010

Source DB:  PubMed          Journal:  Ther Hypothermia Temp Manag        ISSN: 2153-7658            Impact factor:   1.286


  2 in total

1.  Therapeutic hypothermia in stroke and traumatic brain injury.

Authors:  Alireza Faridar; Eric M Bershad; Tenbit Emiru; Paul A Iaizzo; Jose I Suarez; Afshin A Divani
Journal:  Front Neurol       Date:  2011-12-27       Impact factor: 4.003

Review 2.  Protection of Workers Exposed to Radiofrequency Electromagnetic Fields: A Perspective on Open Questions in the Context of the New ICNIRP 2020 Guidelines.

Authors:  Peter Jeschke; Carsten Alteköster; Kjell Hansson Mild; Michel Israel; Mihaela Ivanova; Klaus Schiessl; Tsvetelina Shalamanova; Florian Soyka; Rianne Stam; Jonna Wilén
Journal:  Front Public Health       Date:  2022-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.